## MKSI: MKS Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -3.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($142.53)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. MKS Instruments stock hits 52-week high at 167.38 USD**
- Source: Investing.com | 20251210T145320 | Bullish | Relevance: 100%
- MKS Instruments (MKSI) stock reached a new 52-week high of $167.38, reflecting significant upward growth with a 50.19% return over the past year and 76.09% in six months. Despite being considered overvalued by InvestingPro, analysts remain bullish with price targets up to $200, driven by strong Q3 2025 earnings and positive outlook for its semiconductor business. The company has also maintained dividend payments for 15 consecutive years, further attracting investor attention.

**2. Frontier Capital Management Co. LLC Boosts Stock Position in MKS Inc. $MKSI**
- Source: MarketBeat | 20251211T100952 | Somewhat-Bullish | Relevance: 100%
- Frontier Capital Management Co. LLC significantly increased its stake in MKS Inc. (NASDAQ:MKSI) by 146.4% in the second quarter, acquiring an additional 542,094 shares. MKS now accounts for 0.8% of Frontier Capital's holdings, making it their 17th largest position. Other institutional investors also adjusted their positions in MKSI, and the company has received a "Moderate Buy" consensus rating from analysts with an average target price of $159.64.

**3. Federated Hermes Inc. Purchases 31,815 Shares of MKS Inc. $MKSI**
- Source: MarketBeat | 20251211T090952 | Bullish | Relevance: 100%
- Federated Hermes Inc. increased its stake in MKS Inc. by 38.0% during the second quarter, acquiring an additional 31,815 shares and now owning 0.17% of the company valued at $11.485 million. Other institutional investors also adjusted their holdings in MKS. The company recently declared a quarterly dividend of $0.22 and its stock is trading at $167.88, with a market cap of $11.28 billion.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-12 | Citigroup | $185 | $122 | +52% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-12 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 7 ($1.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (+4.0%)
- Blackrock Inc.: 9.1% (-16.3%)
- Price (T.Rowe) Assoc: 5.4% (-12.0%)
- Victory Capital Mana: 5.3% (-7.3%)
- FMR, LLC: 5.1% (-10.1%)

### Key Risks

1. High beta (1.93) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.61 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.9x). Analyst sentiment positive (1 raises, avg +52%). Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $10.5B |
| Beta | 1.93 |
| 52W Range | $54.84 - $170.37 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.61 |
| Forward P/E | 17.9 |
| Current P/E | 20.2 |
| YoY Growth | 13.2% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.2% to -3.1% (-6.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.1pp (needs >3.0% for momentum thesis). Underperforming sector by 3.0pp, stock-specific weakness. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 52. OFD pattern: -MTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -3.06% (CS: 7) | Weak |
| RSI_14 | 51.9 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.066x | Above |
| vs SMA200 | 1.461x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $155.77
- **Stop Loss:** $142.53 (8.5% risk)
- **Target:** $169.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $11,682.75
- **Portfolio %:** 11.68%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-11 (Est: $2.30)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.85 | $1.93 | +4.1% |
| 2025Q2 | $1.64 | $1.77 | +8.1% |
| 2025Q1 | $1.45 | $1.71 | +17.5% |
| 2024Q4 | $1.96 | $2.15 | +10.0% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*